Autoscriber
PrivateLast Round
Seed
Jan 11, 2023
Total Funding Raised
$1.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Autoscriber operates in Healthcare & Life Sciences and is based in Eindhoven. Its latest recorded funding round was a Seed round in January 2023.
Autoscriber is a healthcare IT company that provides AI-powered software to transcribe and summarize doctor-patient conversations into structured clinical notes.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, NLP & Conversational AI, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autoscriber Comparables
Compare Autoscriber with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noteless | 92% | |
| Tortus | 91% | |
| Delphyr | 89% |
For institutional investors. Book with your work email.
Autoscriber Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 11, 2023 | ||||
| Pre Seed | Sep 7, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Autoscriber Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| LUMO Labs | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 11, 61% of headcount.
- Jul 20, 2026
Open roles increased to 11, 61% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- adopts_technologyOct 30, 2026
On Oct 30th '26, Autoscriber moves medical transcription in Dutch, German, French, and English to Reson8, achieving 62% lower word error rates and five-times-faster transcripts on Reson8-owned GPUs in the Netherlands.
For institutional investors. Book with your work email.
Autoscriber Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Autoscriber's valuation, stock price, and market status.
Is Autoscriber a public or private company?
Autoscriber is a private company.
What is the current stock price of Autoscriber?
Autoscriber is a private company, so its shares have no public market price. Caplight tracks Autoscriber's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Autoscriber worth (valuation)?
Valuation information for Autoscriber is not publicly available.
Can I buy Autoscriber stock?
Autoscriber shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Autoscriber's last funding round?
Autoscriber's most recent funding round was Seed on January 11, 2023.
Who are the main investors in Autoscriber?
Key investors in Autoscriber include LUMO Labs.
Will Autoscriber IPO soon?
No public IPO plans have been announced for Autoscriber.
How can I track Autoscriber secondary market activity?
Caplight tracks bids, offers, and trades in Autoscriber's shares on secondary markets.